179 related articles for article (PubMed ID: 36069231)
21. microRNA from brush biopsy to characterize oral squamous cell carcinoma epithelium.
Zhou Y; Kolokythas A; Schwartz JL; Epstein JB; Adami GR
Cancer Med; 2017 Jan; 6(1):67-78. PubMed ID: 27989009
[TBL] [Abstract][Full Text] [Related]
22. Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis.
Sun Z; Gao W; Cui JT
BMC Oral Health; 2018 Aug; 18(1):143. PubMed ID: 30126398
[TBL] [Abstract][Full Text] [Related]
23. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
[TBL] [Abstract][Full Text] [Related]
24. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y
Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248
[TBL] [Abstract][Full Text] [Related]
25. High-risk human papillomavirus in patients with oral leukoplakia and oral squamous cell carcinoma-A multi-centre study in Sweden, Brazil and Romania.
Sundberg J; Öhman J; Korytowska M; Wallström M; Kjeller G; Andersson M; Horal P; Lindh M; Giglio D; Kovács A; Sand L; Hirsch JM; Magda Araújo Ferracini L; de Souza ACMF; Parlatescu I; Dobre M; Hinescu ME; Braz-Silva PH; Tovaru S; Hasséus B
Oral Dis; 2021 Mar; 27(2):183-192. PubMed ID: 32568421
[TBL] [Abstract][Full Text] [Related]
26. Relationship of the XRCC1 rs25487 polymorphism with demographic, behavioral, clinical, and histological parameters in oral potentially malignant disorders and oral squamous cell carcinoma in a Colombian population.
Hernández-Arenas YY; Támara-De Ávila JJ; Isaza-Guzmán DM; González-Pérez LV; Tobón-Arroyave SI
J Oral Biosci; 2021 Jun; 63(2):217-223. PubMed ID: 33647453
[TBL] [Abstract][Full Text] [Related]
27. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
28. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia.
Yan SK; Wei BJ; Lin ZY; Yang Y; Zhou ZT; Zhang WD
Oral Oncol; 2008 May; 44(5):477-83. PubMed ID: 17936673
[TBL] [Abstract][Full Text] [Related]
29. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
[TBL] [Abstract][Full Text] [Related]
30. Clues toward precision medicine in oral squamous cell carcinoma: utility of next-generation sequencing for the prognostic stratification of high-risk patients harboring neck lymph node extracapsular extension.
Wang HM; Liao CT; Yen TC; Chen SJ; Lee LY; Hsieh CH; Lin CY; Ng SH
Oncotarget; 2016 Sep; 7(39):63082-63092. PubMed ID: 27590518
[TBL] [Abstract][Full Text] [Related]
31. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma.
Nagata S; Hamada T; Yamada N; Yokoyama S; Kitamoto S; Kanmura Y; Nomura M; Kamikawa Y; Yonezawa S; Sugihara K
Cancer; 2012 Sep; 118(17):4298-308. PubMed ID: 22252571
[TBL] [Abstract][Full Text] [Related]
32. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.
Chang PY; Kuo YB; Wu TL; Liao CT; Sun YC; Yen TC; Chan EC
Clin Chem Lab Med; 2013 Jun; 51(6):1291-300. PubMed ID: 23154424
[TBL] [Abstract][Full Text] [Related]
33. Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.
Errazquin R; Page A; Suñol A; Segrelles C; Carrasco E; Peral J; Garrido-Aranda A; Del Marro S; Ortiz J; Lorz C; Minguillon J; Surralles J; Belendez C; Alvarez M; Balmaña J; Bravo A; Ramirez A; Garcia-Escudero R
Oral Oncol; 2022 Nov; 134():106184. PubMed ID: 36191479
[TBL] [Abstract][Full Text] [Related]
34. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
35. PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma.
Miyahara LAN; Pontes FSC; Burbano RMR; Conte Neto N; Guimarães DM; Fonseca FP; Pontes HAR
Histopathology; 2018 Jan; 72(2):330-338. PubMed ID: 28858374
[TBL] [Abstract][Full Text] [Related]
36. Molecular and Immunohistochemical Cognizance of HPV16 in Oral Leukoplakia, Oral Squamous Cell Carcinoma and Oropharyngeal Squamous Cell Carcinoma.
Sivakumar N; Narwal A; Kamboj M; Devi A; Kumar S; Bhardwaj R
Head Neck Pathol; 2021 Sep; 15(3):882-892. PubMed ID: 33646558
[TBL] [Abstract][Full Text] [Related]
37. Relevance and actionable mutational spectrum in oral squamous cell carcinoma.
Jayaprakash C; Varghese VK; Jayaram P; Chakrabarty S; Kudva A; Ray S; Satyamoorthy K
J Oral Pathol Med; 2020 May; 49(5):427-434. PubMed ID: 31845386
[TBL] [Abstract][Full Text] [Related]
38. Lack of molecular markers to predict malignant potential of oral precancer.
Warnakulasuriya S
J Pathol; 2000 Mar; 190(4):407-9. PubMed ID: 10699986
[TBL] [Abstract][Full Text] [Related]
39. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
[TBL] [Abstract][Full Text] [Related]
40. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
Liu W; Yao Y; Shi L; Tang G; Wu L
J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
